WTW Quote, Financials, Valuation and Earnings

Berkshire Hathaway, Inc. has a net margin of 13.37% compared to Willis Towers Watson Plc's net margin of 32.5%. Willis Towers Watson Plc's return on equity of 26.7% beat Berkshire Hathaway, Inc.'s return on equity of 10.23%.

Willis Towers Watson Plc has a consensus price target of $365.22, signalling upside risk potential of 15.38%. On the other hand Berkshire Hathaway, Inc. has an analysts' consensus of $767,689.50 which suggests that it could grow by 1.38%. Given that Willis Towers Watson Plc has higher upside potential than Berkshire Hathaway, Inc., analysts believe Willis Towers Watson Plc is more attractive than Berkshire Hathaway, Inc..

Willis Towers Watson Plc has a beta of 0.629, which suggesting that the stock is 37.121% less volatile than S&P 500. In comparison Berkshire Hathaway, Inc. has a beta of 0.702, suggesting its less volatile than the S&P 500 by 29.818%.

Willis Towers Watson Plc has a quarterly dividend of $0.92 per share corresponding to a yield of 1.15%. Berkshire Hathaway, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Willis Towers Watson Plc pays 402.27% of its earnings as a dividend. Berkshire Hathaway, Inc. pays out -- of its earnings as a dividend.

Willis Towers Watson Plc quarterly revenues are $2.3B, which are smaller than Berkshire Hathaway, Inc. quarterly revenues of $95B. Willis Towers Watson Plc's net income of $306M is lower than Berkshire Hathaway, Inc.'s net income of $30.9B. Notably, Willis Towers Watson Plc's price-to-earnings ratio is 15.11x while Berkshire Hathaway, Inc.'s PE ratio is 16.16x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Willis Towers Watson Plc is 3.23x versus 2,198.64x for Berkshire Hathaway, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Brown & Brown, Inc. has a net margin of 13.37% compared to Willis Towers Watson Plc's net margin of 14.14%. Willis Towers Watson Plc's return on equity of 26.7% beat Brown & Brown, Inc.'s return on equity of 11.39%.

Willis Towers Watson Plc has a consensus price target of $365.22, signalling upside risk potential of 15.38%. On the other hand Brown & Brown, Inc. has an analysts' consensus of $93.50 which suggests that it could grow by 17.39%. Given that Brown & Brown, Inc. has higher upside potential than Willis Towers Watson Plc, analysts believe Brown & Brown, Inc. is more attractive than Willis Towers Watson Plc.

Willis Towers Watson Plc has a beta of 0.629, which suggesting that the stock is 37.121% less volatile than S&P 500. In comparison Brown & Brown, Inc. has a beta of 0.816, suggesting its less volatile than the S&P 500 by 18.449%.

Willis Towers Watson Plc has a quarterly dividend of $0.92 per share corresponding to a yield of 1.15%. Brown & Brown, Inc. offers a yield of 0.77% to investors and pays a quarterly dividend of $0.17 per share. Willis Towers Watson Plc pays 402.27% of its earnings as a dividend. Brown & Brown, Inc. pays out 15.63% of its earnings as a dividend. Brown & Brown, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Willis Towers Watson Plc's is not.

Willis Towers Watson Plc quarterly revenues are $2.3B, which are larger than Brown & Brown, Inc. quarterly revenues of $1.6B. Willis Towers Watson Plc's net income of $306M is higher than Brown & Brown, Inc.'s net income of $227M. Notably, Willis Towers Watson Plc's price-to-earnings ratio is 15.11x while Brown & Brown, Inc.'s PE ratio is 23.90x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Willis Towers Watson Plc is 3.23x versus 4.34x for Brown & Brown, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

eHealth, Inc. has a net margin of 13.37% compared to Willis Towers Watson Plc's net margin of -58.83%. Willis Towers Watson Plc's return on equity of 26.7% beat eHealth, Inc.'s return on equity of 5.62%.

Willis Towers Watson Plc has a consensus price target of $365.22, signalling upside risk potential of 15.38%. On the other hand eHealth, Inc. has an analysts' consensus of $8.50 which suggests that it could grow by 104.33%. Given that eHealth, Inc. has higher upside potential than Willis Towers Watson Plc, analysts believe eHealth, Inc. is more attractive than Willis Towers Watson Plc.

Willis Towers Watson Plc has a beta of 0.629, which suggesting that the stock is 37.121% less volatile than S&P 500. In comparison eHealth, Inc. has a beta of 1.271, suggesting its more volatile than the S&P 500 by 27.113%.

Willis Towers Watson Plc has a quarterly dividend of $0.92 per share corresponding to a yield of 1.15%. eHealth, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Willis Towers Watson Plc pays 402.27% of its earnings as a dividend. eHealth, Inc. pays out -55.3% of its earnings as a dividend.

Willis Towers Watson Plc quarterly revenues are $2.3B, which are larger than eHealth, Inc. quarterly revenues of $53.9M. Willis Towers Watson Plc's net income of $306M is higher than eHealth, Inc.'s net income of -$31.7M. Notably, Willis Towers Watson Plc's price-to-earnings ratio is 15.11x while eHealth, Inc.'s PE ratio is 112.13x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Willis Towers Watson Plc is 3.23x versus 0.23x for eHealth, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Marsh & McLennan Cos., Inc. has a net margin of 13.37% compared to Willis Towers Watson Plc's net margin of 11.89%. Willis Towers Watson Plc's return on equity of 26.7% beat Marsh & McLennan Cos., Inc.'s return on equity of 28.77%.

Willis Towers Watson Plc has a consensus price target of $365.22, signalling upside risk potential of 15.38%. On the other hand Marsh & McLennan Cos., Inc. has an analysts' consensus of $211.85 which suggests that it could grow by 15.49%. Given that Marsh & McLennan Cos., Inc. has higher upside potential than Willis Towers Watson Plc, analysts believe Marsh & McLennan Cos., Inc. is more attractive than Willis Towers Watson Plc.

Willis Towers Watson Plc has a beta of 0.629, which suggesting that the stock is 37.121% less volatile than S&P 500. In comparison Marsh & McLennan Cos., Inc. has a beta of 0.755, suggesting its less volatile than the S&P 500 by 24.514%.

Willis Towers Watson Plc has a quarterly dividend of $0.92 per share corresponding to a yield of 1.15%. Marsh & McLennan Cos., Inc. offers a yield of 1.87% to investors and pays a quarterly dividend of $0.90 per share. Willis Towers Watson Plc pays 402.27% of its earnings as a dividend. Marsh & McLennan Cos., Inc. pays out 38.54% of its earnings as a dividend. Marsh & McLennan Cos., Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Willis Towers Watson Plc's is not.

Willis Towers Watson Plc quarterly revenues are $2.3B, which are smaller than Marsh & McLennan Cos., Inc. quarterly revenues of $6.4B. Willis Towers Watson Plc's net income of $306M is lower than Marsh & McLennan Cos., Inc.'s net income of $757M. Notably, Willis Towers Watson Plc's price-to-earnings ratio is 15.11x while Marsh & McLennan Cos., Inc.'s PE ratio is 22.05x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Willis Towers Watson Plc is 3.23x versus 3.44x for Marsh & McLennan Cos., Inc.. Usually stocks with elevated PS ratios are considered overvalued.